The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study | PLOS Medicine
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension
Frontiers | From Self-Esteem to Selflessness: An Evidence (Gap) Map of Self-Related Processes as Mechanisms of Mindfulness-Based Interventions
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction
The Daily Herald - Why Relative Risk Reduction, not Absolute Risk Reduction, is most often used in calculating vaccine efficacy
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis | Scientific Reports
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response | PLOS ONE
PolitiFact | Instagram post misleads on vaccine efficacy by conflating two different measures
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 | Nature Communications
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Testing fractional doses of COVID-19 vaccines | PNAS
Differences in relative and absolute effectiveness of oral P2Y12 inhibition in men and women: a meta-analysis and modelling stud
Prolia® (denosumab) Pivotal 3-Year Fracture Study Efficacy Data | Prolia®
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy - ScienceDirect
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat | CMAJ
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ
TOBI® PODHALER® | Efficacy and Clinical Trials
Relative risk reduction - Wikipedia
Safety Versus Efficacy Data - Trial Monitoring | Coursera
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room - The Lancet Microbe
Fact Check-Why Relative Risk Reduction, not Absolute Risk Reduction, is most often used in calculating vaccine efficacy | Reuters
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks | medRxiv
